# Conventional vs. Automated Identification Systems

## Quick Answer

- Automated microbial identification systems reduce turnaround time and hands-on labor compared to conventional biochemical and phenotypic methods, but require significant capital investment and ongoing maintenance costs.
- Laboratory managers should evaluate annual test volume, staffing costs, and required time-to-result before choosing between conventional and automated approaches.
- Neither method is universally superior, and accuracy depends on the organism panel, culture quality, and operator proficiency with the selected system.

## At a Glance

| Factor | Conventional Methods | Automated Systems |
|--------|---------------------|-------------------|
| Turnaround time | 24 to 72 hours or longer depending on organism growth and biochemical test incubation | 4 to 24 hours for many organisms after pure culture is obtained |
| Cost per test | Lower instrument cost, higher consumable cost per test, significant labor time | Higher instrument and maintenance cost, lower per-test consumable cost at volume |
| Labor requirements | Extensive hands-on time for inoculation, reading, and interpretation | Reduced hands-on time, requires training for instrument operation and software |
| Accuracy | Depends on technician skill and test panel breadth | Depends on database coverage and organism diversity |
| Throughput capacity | Limited by bench space and technician availability | Scales with instrument capacity and batch processing |
| Best fit | Low-volume laboratories, reference confirmation, specialized organisms | High-volume clinical and food laboratories with consistent workflow |

## Understanding Microbial Identification Systems

Microbial identification is the process of determining the genus and species of a bacterial or fungal isolate recovered from a clinical, environmental, or food sample. The choice between conventional and automated identification systems affects laboratory workflow, result accuracy, and operational cost. Conventional methods rely on biochemical reactions, sugar fermentation patterns, and enzymatic activity observed over hours or days. Automated systems use instrument-based detection of these same biochemical principles or alternative technologies such as mass spectrometry to generate results with less manual intervention.

The decision to adopt automated identification is not a simple upgrade. It changes how laboratory staff spend their time, how results are documented, and how quality control is performed. The Clinical and Laboratory Standards Institute provides standards-based guidance for antimicrobial susceptibility testing and related microbiology practices, which is relevant when laboratories integrate identification with susceptibility workflows [<a href="#ref-1">1</a>]. The American Society for Microbiology offers professional education and laboratory practice context that supports training decisions for both conventional and automated approaches [<a href="#ref-2">2</a>].

Laboratory managers must consider the full workflow, from specimen processing to final result reporting. Conventional methods are often deeply embedded in laboratory protocols and staff training. Automated systems require new skills, maintenance routines, and troubleshooting procedures. The decision affects also the identification step but also downstream processes such as antimicrobial susceptibility testing and result reporting.

## Core Principles of Conventional Identification

Conventional microbial identification is built on observable biochemical and phenotypic characteristics. These methods have been refined over decades and remain the standard for many laboratories, particularly those with low test volumes or specialized testing needs.

### Biochemical and Phenotypic Principles

Conventional identification uses the metabolic capabilities of microorganisms to distinguish between species. A panel of biochemical tests is selected based on the Gram reaction, cellular morphology, and colony characteristics of the isolate. Each test detects a specific metabolic activity, such as carbohydrate fermentation, enzyme production, or utilization of a particular substrate. The pattern of positive and negative reactions is compared to established databases to determine the most likely species identification.

The accuracy of conventional methods depends on the number and quality of tests performed. A limited panel may not distinguish between closely related species. The American Type Culture Collection maintains authenticated biological materials and strain information that laboratories can use to verify the performance of their identification tests [<a href="#ref-3">3</a>]. Reference strains with known biochemical profiles are essential for quality control in conventional identification.

### Culture Media and Growth Requirements

Conventional identification begins with the isolation of a pure culture. The quality of the culture directly affects the reliability of biochemical tests. Media must support the growth of the target organism without suppressing the expression of key metabolic pathways. The FDA Bacteriological Analytical Manual [<a href="#ref-4">4</a>] describes official food microbiology methods that rely on conventional culture and biochemical identification, providing a reference for laboratories that test food samples.

Growth conditions, including temperature, atmosphere, and incubation time, must be controlled. Some organisms require specialized media or extended incubation periods. The laboratory must document the growth conditions used for each identification to ensure that results are reproducible and interpretable.

### Interpretation of Biochemical Profiles

The interpretation of conventional biochemical tests requires trained personnel who can recognize the expected reactions and identify unusual or ambiguous results. The pattern of positive and negative reactions is compared to published tables or databases. The laboratory must have access to current reference data and must verify that the database includes the species commonly encountered in the laboratory.

Interpretation errors can occur when the organism has an atypical biochemical profile or when the test panel is insufficient to distinguish between closely related species. The laboratory should have a protocol for resolving ambiguous results, including repeating tests, performing additional tests, or referring the isolate to a reference laboratory.

## Core Principles of Automated Identification

Automated identification systems are designed to reduce the manual steps in microbial identification and to standardize the interpretation of results. These systems use instrument-based detection of biochemical reactions, or they use alternative technologies such as matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to identify organisms by their protein profile.

### Instrument-Based Biochemical Detection

Automated biochemical identification systems use panels or cards that contain multiple biochemical substrates. The instrument inoculates the panel with a standardized suspension of the organism, incubates it, and reads the reactions at defined intervals. The system compares the reaction pattern to a database and reports the most likely identification.

The advantage of these systems is the standardization of the test conditions and the automated reading of results. The instrument controls the inoculum density, incubation time, and reading wavelength, which reduces the variability introduced by manual methods. The system also provides a digital record of the results, which supports documentation and quality assurance.

### Mass Spectrometry-Based Identification

MALDI-TOF MS is a newer technology that identifies organisms by analyzing the protein profile of the intact cell. A small amount of the organism is placed on a target plate, mixed with a matrix solution, and analyzed by the instrument. The resulting spectrum is compared to a reference database to determine the species.

MALDI-TOF MS is faster than biochemical methods, with results available in minutes after a pure culture is obtained. The cost per test is lower than that of biochemical panels, and the system can identify a wide range of organisms. The accuracy of MALDI-TOF MS depends on the quality of the database and the quality of the sample preparation.

### Database and Software Considerations

Automated systems rely on databases that contain the reference profiles of the organisms the system can identify. The laboratory must verify that the database includes the organisms relevant to its patient population or sample types. The database must be updated regularly to include newly described species and to correct errors in the reference profiles.

The software that operates the instrument and interprets the results is a critical component of the automated system. The laboratory must have trained personnel who can operate the software, interpret the results, and troubleshoot instrument errors. The software should provide a clear record of the results and the confidence level of the identification.

## Workflow Comparison

The workflow for microbial identification differs between conventional and automated methods. The choice of workflow affects the time to result, the number of staff required, and the cost per test.

### Specimen Processing and Culture

Both conventional and automated methods require a pure culture of the organism. The specimen is first cultured on a primary isolation medium, and the colonies are examined for morphology and purity. The time required for this step is the same for both methods and depends on the growth rate of the organism.

### Inoculation and Incubation

Conventional methods require the manual inoculation of each biochemical test. The technician must prepare the inoculum, inoculate each tube or plate, and place the tests in the appropriate incubation conditions. The incubation time is typically 18 to 24 hours, but some tests require longer.

Automated systems require the preparation of a standardized suspension of the organism. The suspension is used to inoculate the panel or card, which is then placed in the instrument. The instrument controls the incubation and reads the results at the appropriate time. The hands-on time is reduced, but the instrument must be maintained and calibrated.

### Result Reading and Interpretation

Conventional methods require the technician to read each test and record the results. The interpretation is performed manually, and the technician must have the expertise to recognize the expected reactions and to identify unusual results. The results are recorded in the laboratory information system.

Automated systems read the results automatically and provide an identification report. The technician reviews the report and verifies that the identification is consistent with the organism morphology and the clinical context. The system provides a record of the results that can be transferred to the laboratory information system.

### Turnaround Time

The turnaround time for conventional methods is typically 24 to 72 hours after the pure culture is obtained. The time depends on the number of tests performed and the incubation time required. Automated systems can provide an identification in 4 to 24 hours, depending on the technology and the organism.

MALDI-TOF MS provides the fastest turnaround, with results available in minutes after the pure culture is obtained. The time saved can be significant for laboratories that need to provide rapid results for patient care or food safety.

## Cost Analysis

The cost of microbial identification includes the cost of the instrument, the consumables, the labor, and the maintenance. The cost per test depends on the volume of tests performed and the efficiency of the laboratory.

### Instrument and Capital Costs

Conventional methods require minimal capital investment. The laboratory needs basic equipment such as incubators, autoclaves, and a microscope. The cost of this equipment is typically lower than the cost of an automated system.

Automated systems require a significant capital investment. The instrument can cost tens of thousands to hundreds of thousands of dollars, depending on the technology and the capacity. The laboratory must also budget for installation, training, and validation of the system.

### Consumable Costs

Conventional methods require the purchase of biochemical test media, reagents, and supplies. The cost per test is relatively low, but the cost of the consumables can add up over time. The laboratory must also consider the cost of quality control organisms and media.

Automated systems require the purchase of panels, cards, or target plates. The cost per test is higher than the cost of conventional consumables, but the cost per test decreases as the volume of tests increases. The laboratory must also budget for the cost of the matrix and other supplies for MALDI-TOF MS.

### Labor Costs

Labor is a significant component of the cost of microbial identification. Conventional methods require a technician to perform the tests, read the results, and interpret the data. The labor time is typically 10 to 30 minutes per isolate, depending on the number of tests performed.

Automated systems reduce the hands-on time to 5 to 10 minutes per isolate. The technician is required to prepare the suspension, inoculate the panel, and confirm the results. The time saved can be used for other laboratory tasks or to increase the throughput of the laboratory.

### Total Cost per Test

The total cost per test is the sum of the consumable cost, the labor cost, and the amortized instrument cost. The cost per test for conventional methods is typically lower for low-volume laboratories, but the cost per test increases as the volume increases due to the labor required. The cost per test for automated systems is higher for low-volume laboratories, but the cost per test decreases as the volume increases.

## Accuracy and Performance

The accuracy of microbial identification is a critical factor in the choice of method. The accuracy of conventional methods depends on the skill of the technician and the number of tests performed. The accuracy of automated systems depends on the quality of the database and the performance of the instrument.

### Accuracy of Conventional Methods

Conventional methods are accurate when performed correctly and when the test panel is appropriate for the organism. The accuracy of the method depends on the number of tests performed and the quality of the reference data. The laboratory must use authenticated reference organisms to verify the performance of the tests.

The accuracy of conventional methods can be limited by the number of tests performed. A limited panel may not distinguish between closely related species. The laboratory must have a protocol for escalating ambiguous results to a reference laboratory.

### Accuracy of Automated Systems

Automated systems are designed to provide accurate and reproducible results. The accuracy of the system depends on the quality of the database and the coverage of the organism panel. The system should be validated with a panel of known organisms before it is used for routine testing.

The accuracy of MALDI-TOF MS is high for organisms that are well represented in the database. The accuracy can be lower for organisms that are not well represented or for organisms that have a similar protein profile. The laboratory must verify the accuracy of the system for the organisms it encounters.

### Quality Control

Quality control is essential for both conventional and automated methods. The laboratory must use authenticated reference organisms to verify the performance of the tests. The American Type Culture Collection [<a href="#ref-3">3</a>] provides authenticated biological materials that can be used for quality control.

The laboratory must also participate in external quality assessment programs to verify the accuracy of its results. The results of the quality control tests must be documented and reviewed.

## Practical Implementation Steps

The decision to adopt an automated system requires a structured approach. The laboratory manager should evaluate the needs of the laboratory, the available budget, and the training requirements.

### Step 1: Assess the Laboratory Workload

The laboratory should determine the number of isolates that are identified each day or each week. The workload should be assessed over a period of time to account for seasonal variation. The laboratory should also assess the types of organisms that are identified and the turnaround time required.

### Step 2: Evaluate the Budget

The laboratory should evaluate the capital budget for the instrument and the operating budget for the consumables and maintenance. The laboratory should also consider the cost of training and the cost of the downtime for the instrument.

### Step 3: Compare the Methods

The laboratory should compare the turnaround time, the cost per test, and the accuracy of the methods. The comparison should be based on the specific needs of the laboratory, including the volume of tests, the type of organisms, and the required turnaround time.

### Step 4: Select the System

The laboratory should select the system that best meets its needs. The selection should be based on the evidence from the comparison and the input of the laboratory staff. The laboratory should also consider the support and training provided by the manufacturer.

### Step 5: Validate the System

The laboratory should validate the system before it is used for routine testing. The validation should include a panel of organisms that are representative of the laboratory's workload. The results of the validation should be compared to the results of the reference method.

### Step 6: Train the Staff

The laboratory should train the staff on the operation of the system. The training should include the preparation of the inoculum, the operation of the instrument, and the interpretation of the results. The training should be documented and the staff should be assessed for competency.

### Step 7: Implement the System

The laboratory should implement the system in a phased approach. The laboratory should monitor the performance of the system and the results of the quality control tests. The laboratory should also monitor the turnaround time and the cost of the system.

## Records and Measurements

The laboratory should maintain records of the performance of the identification system. The records should include the results of the quality control tests, the results of the validation, and the results of the routine tests.

### Quality Control Records

The laboratory should maintain records of the quality control tests performed for each batch of media and reagents. The records should include the organism used, the expected result, and the observed result. The records should be reviewed by the laboratory supervisor.

### Validation Records

The laboratory should maintain records of the validation of the automated system. The records should include the panel of organisms used, the results of the validation, and the comparison to the reference method. The records should be reviewed by the laboratory director.

### Routine Test Records

The laboratory should maintain records of the routine tests performed. The records should include the identification of the organism, the method used, and the result. The records should be stored in the laboratory information system.

## Common Failure Patterns

The laboratory should be aware of the common failure patterns that can affect the accuracy of the identification. The failure patterns can be related to the specimen, the culture, or the test.

### Contamination of the Culture

The contamination of the culture is a common cause of inaccurate identification. The contamination can occur during the collection of the specimen, the culture of the organism, or the preparation of the inoculum. The laboratory should use aseptic technique to prevent contamination.

### Insufficient Growth

The insufficient growth of the organism can cause the identification to fail. The organism may not grow on the media or the incubation conditions may not be appropriate. The laboratory should verify the growth of the organism before performing the identification.

### Database Limitations

The database of the automated system may not include the organism that is being identified. The system may report an incorrect identification or no identification. The laboratory should verify the identification with a reference method.

### Instrument Malfunction

The instrument may malfunction, causing the identification to fail. The laboratory should monitor the instrument for errors and perform the maintenance as recommended by the manufacturer.

## Biosafety and Containment

The laboratory must follow the biosafety principles described in the Biosafety in Microbiological and Biomedical Laboratories [<a href="#ref-5">5</a>]. The laboratory must assess the risk of the organisms being handled and use the appropriate containment and decontamination procedures.

### Risk Assessment

The laboratory must perform a risk assessment for the organisms being handled. The risk assessment should consider the pathogenicity of the organism, the route of transmission, and the laboratory procedures being performed. The risk assessment should be documented and reviewed.

### Containment

The laboratory must use the appropriate containment for the organisms being handled. The containment should include the use of a biological safety cabinet for procedures that generate aerosols. The laboratory should also use the appropriate personal protective equipment.

### Decontamination

The laboratory must decontaminate the work surfaces and the equipment after the procedures are completed. The decontamination should be performed using an appropriate disinfectant. The laboratory should also decontaminate the waste before disposal.

## Antimicrobial Resistance Context

The choice of identification method is related to the global problem of antimicrobial resistance. The World Health Organization [<a href="#ref-6">6</a>] defines antimicrobial resistance as the ability of a microorganism to resist the effects of an antimicrobial agent. The identification of the organism is the first step in the management of antimicrobial resistance.

### The Role of Identification in Stewardship

The identification of the organism is essential for the selection of the appropriate antimicrobial therapy. The identification of the organism can also be used to detect the emergence of resistant strains. The laboratory should provide the identification of the organism in a timely manner to support the antimicrobial stewardship.

### The Role of Susceptibility Testing

The identification of the organism is often followed by the antimicrobial susceptibility testing. The susceptibility testing is performed using the standards of the Clinical and Laboratory Standards Institute [<a href="#ref-1">1</a>]. The results of the susceptibility testing are used to guide the antimicrobial therapy.

## Professional Escalation Criteria

The laboratory should have a protocol for escalating the results of the identification to the appropriate personnel. The escalation should be performed when the identification is unusual, when the organism is a potential biothreat, or when the identification is not consistent with the clinical picture.

### Unusual Identification

The laboratory should escalate the identification when the organism is not commonly encountered in the laboratory. The laboratory should confirm the identification with a reference method or refer the specimen to a reference laboratory.

### Potential Biothreat

The laboratory should escalate the identification when the organism is a potential biothreat. The laboratory should follow the protocols of the laboratory for the handling of the potential biothreat. The laboratory should notify the appropriate authorities.

### Inconsistent Results

The laboratory should escalate the identification when the result is not consistent with the clinical picture. The laboratory should review the specimen and the culture to determine the cause of the inconsistency.

## Decision Framework for Method Selection Based on Workload and Budget

Laboratory managers often struggle to translate general cost and turnaround comparisons into a concrete decision for their specific facility. A structured decision framework that uses measurable laboratory data can resolve this problem. This framework focuses on the two variables that most directly determine whether automation is justified: annual isolate volume and available labor hours. The framework also accounts for the hidden costs of method switching, including validation time, staff retraining, and workflow disruption.

### Workload Threshold Assessment

The first step in the decision framework is to calculate the annual isolate volume for identification testing. This calculation should include all isolates that require species-level identification, beyond those that are part of routine workflows. The laboratory should review its records for the previous 12 months and count the number of isolates that were identified by any method. This count should be separated by organism type because some organisms require additional testing or extended incubation.

The workload assessment should also include the distribution of isolates across the workweek. A laboratory that receives 50 isolates per week but receives 30 of them on Monday will have different staffing needs than a laboratory that receives 10 isolates per day consistently. The peak workload determines the number of staff required and the capacity of the instrument. The laboratory should document the daily isolate count for at least three months to capture the variation in the workload.

The workload assessment should also consider the source of the isolates. A laboratory that identifies organisms from blood cultures will have different turnaround time requirements than a laboratory that identifies organisms from environmental samples. The urgency of the results affects the value of the faster turnaround time provided by automated systems. The laboratory should document the proportion of isolates that require urgent identification and the time frame for the results.

### Labor Cost Calculation

The labor cost per isolate is a critical input to the decision framework. The laboratory should measure the hands-on time required for each identification method. This measurement should be performed by observing the technician during the actual workflow, not by estimating from the manufacturer documentation. The observation should include the time required for the preparation of the inoculum, the inoculation of the tests, the reading of the results, and the interpretation of the results.

The hands-on time for conventional methods should be measured for each type of organism and each test panel. The time will vary depending on the number of tests performed and the experience of the technician. The laboratory should measure the time for at least 10 isolates to obtain a reliable average. The time should be recorded in minutes and converted to a cost using the hourly wage of the technician plus the cost of the benefits.

The hands-on time for automated systems should be measured in the same way. The time for the preparation of the suspension, the inoculation of the panel, and the confirmation of the results should be recorded. The time for the instrument operation and the maintenance should also be recorded. The laboratory should measure the time for at least 10 isolates to obtain a reliable average.

The labor cost per isolate is calculated by multiplying the hands-on time by the hourly cost of the technician. The labor cost should be calculated for both methods and compared. The difference in the labor cost is the labor savings that can be attributed to the automated system. The labor savings should be multiplied by the annual isolate volume to determine the annual labor savings.

### Break-Even Volume Calculation

The break-even volume is the annual isolate count at which the cost of the automated system equals the cost of the conventional method. This calculation provides a clear threshold for the decision. The calculation requires the following inputs: the capital cost of the instrument, the annual maintenance cost, the cost per test for the consumables, the labor cost per isolate for each method, and the annual isolate volume.

The annual cost of the conventional method is the sum of the consumable cost per test multiplied by the annual volume and the labor cost per isolate multiplied by the annual volume. The annual cost of the automated method is the sum of the consumable cost per test multiplied by the annual volume, the labor cost per isolate multiplied by the annual volume, the annual maintenance cost, and the amortized capital cost. The amortized capital cost is the instrument cost divided by the expected life of the instrument in years.

The break-even volume is the volume at which the annual cost of the two methods is equal. The formula can be solved for the volume. The laboratory should calculate the break-even volume using its own cost data. The calculation should be performed for the expected life of the instrument, which is typically five to seven years.

The break-even volume provides a clear threshold for the decision. If the annual isolate volume is above the break-even volume, the automated system is likely to be cost-effective. If the annual isolate volume is below the break-even volume, the conventional method is likely to be more cost-effective. The break-even volume should be used as a starting point for the decision, not as the only factor.

### Cost of Method Failure

The decision framework should also include the cost of method failure. A failed identification requires a repeat test, which consumes additional consumables and labor time. The cost of the repeat test should be included in the cost analysis. The laboratory should track the rate of failed identifications for each method. The failure rate should be calculated as the number of failed identifications divided by the total number of identifications.

The cost of the failed identification is the cost of the consumables for the repeat test plus the labor cost for the repeat test. The cost of the failed identification should be multiplied by the annual volume and the failure rate to determine the annual cost of the failures. The cost of the failures should be added to the annual cost of the method.

The failure rate for conventional methods is often higher than the failure rate for automated methods. The failure rate for conventional methods depends on the skill of the technician and the quality of the test panel. The failure rate for automated methods depends on the quality of the database and the quality of the sample preparation. The laboratory should use its own failure rate data, not the manufacturer's claims.

### Validation and Implementation Cost

The decision framework should include the cost of the validation and the implementation of the automated system. The validation cost includes the cost of the reference organisms, the cost of the consumables used for the validation, and the labor cost of the validation. The validation should be performed using a panel of organisms that are representative of the laboratory workload. The American Type Culture Collection provides authenticated biological materials that can be used for the validation [<a href="#ref-3">3</a>].

The implementation cost includes the cost of the training for the staff and the cost of the downtime during the implementation. The training should be documented and the staff should be assessed for competency. The American Society for Microbiology offers professional education and laboratory practice context that supports training decisions for both conventional and automated approaches [<a href="#ref-2">2</a>]. The implementation cost should be added to the capital cost of the instrument for the break-even calculation.

### Decision Matrix for Method Selection

The decision matrix provides a structured way to compare the methods based on the laboratory data. The matrix should include the following criteria: the annual isolate volume, the labor cost per isolate, the turnaround time requirement, the accuracy requirement, and the available budget. The laboratory should assign a weight to each criterion based on the priorities of the laboratory.

The annual isolate volume should be compared to the break-even volume. If the volume is above the break-even volume, the automated system should be considered. If the volume is below the break-even volume, the conventional method should be considered. The labor cost per isolate should be compared between the methods. The turnaround time requirement should be compared to the turnaround time of the methods. The accuracy requirement should be compared to the accuracy of the methods.

The available budget should be compared to the capital cost of the instrument. The laboratory should also consider the operating budget for the consumables and the maintenance. The decision matrix should be used to document the decision and to provide a basis for the review of the decision.

### Escalation Criteria for the Decision

The laboratory should have a protocol for escalating the decision to the laboratory director or the hospital administration. The escalation should be performed when the capital cost of the instrument exceeds the available budget, when the decision requires a change in the staffing model, or when the decision affects the accreditation status of the laboratory.

The escalation should include a written proposal that documents the workload data, the cost analysis, and the decision matrix. The proposal should be reviewed by the laboratory director and the hospital administration. The proposal should include the expected benefits of the automated system, including the turnaround time, the labor savings, and the accuracy.

The escalation should also be performed when the laboratory is considering a change from an automated system to a conventional method. The change may be required when the volume of the tests decreases, when the budget is reduced, or when the automated system is no longer supported by the manufacturer. The escalation should include the same documentation as the proposal for the automated system.

### Monitoring the Decision

The laboratory should monitor the performance of the selected method after the implementation. The monitoring should include the turnaround time, the cost per test, the failure rate, and the labor time. The monitoring should be performed for at least six months after the implementation. The results of the monitoring should be compared to the projections used in the decision framework.

The monitoring should be documented and reviewed by the laboratory director. The review should identify any discrepancies between the projected and the actual performance. The review should also identify any opportunities for the improvement of the workflow. The monitoring should be used to adjust the decision if the actual performance does not meet the projections.

The laboratory should also monitor the quality of the results. The laboratory should participate in the external quality assessment programs to verify the accuracy of the results. The results of the quality assessment should be reviewed and the corrective actions should be taken if the results are not satisfactory. The quality assessment should be documented and reviewed.

The decision framework should be reviewed annually. The review should include the annual isolate volume, the cost of the consumables, the labor cost, and the failure rate. The review should be used to determine if the decision is still appropriate. The review should be documented and the changes should be made if the data support the changes.

### Records for the Decision Framework

The laboratory should maintain records of the decision framework. The records should include the workload assessment, the labor cost calculation, the break-even analysis, and the decision matrix. The records should be reviewed by the laboratory director and the hospital administration.

The records should include the data used for the calculations. The records should include the annual isolate volume, the hands-on time for each method, the hourly cost of the technician, the cost of the consumables, and the cost of the instrument. The records should be stored in a format that can be reviewed and updated.

The records should also include the monitoring data. The records should include the cost per test, the failure rate, and the labor time for each month. The records should be reviewed to identify the trends and the changes in the performance. The records should be used to update the decision framework.

The records should be reviewed by the laboratory director at least annually. The review should be documented and the changes should be made if the data support the changes. The review should also be used to identify the opportunities for the improvement of the workflow.

### Common Failure Patterns in the Decision Process

The laboratory should be aware of the common failure patterns in the decision process. The failure patterns can lead to the selection of the wrong method and the waste of the resources.

The first failure pattern is the use of the manufacturer data instead of the laboratory data. The manufacturer data may not reflect the actual performance of the system in the laboratory. The laboratory should use its own data for the workload, the labor cost, and the failure rate.

The second failure pattern is the failure to include the cost of the validation and the implementation. The validation and the implementation can add a significant cost to the automated system. The cost should be included in the break-even analysis.

The third failure pattern is the failure to consider the cost of the downtime. The downtime of the instrument can cause the delay of the results and the increase of the cost. The laboratory should include the cost of the downtime in the analysis.

The fourth failure pattern is the failure to consider the training of the staff. The training of the staff can take time and can affect the workflow. The laboratory should include the cost of the training in the analysis.

The fifth failure pattern is the failure to review the decision after the implementation. The decision should be reviewed annually to ensure that the decision is still appropriate. The review should be based on the actual data, not the projections.

### Biosafety and Containment in the Decision Process

The decision process should also consider the biosafety and the containment requirements of the laboratory. The laboratory must follow the biosafety principles described in the Biosafety in Microbiological and Biomedical Laboratories [<a href="#ref-5">5</a>]. The biosafety requirements can affect the cost of the method and the workflow.

The automated system may require the use of a biological safety cabinet for the preparation of the inoculum. The conventional method may also require the use of a biological safety cabinet for the inoculation of the tests. The laboratory should include the cost of the biological safety cabinet in the analysis.

The automated system may generate aerosols during the operation of the instrument. The laboratory should assess the risk of the aerosols and use the appropriate containment. The laboratory should also decontaminate the instrument and the work surfaces after the procedures are completed.

The laboratory should also consider the decontamination of the waste. The waste from the automated system may include the panels, the cards, and the target plates. The waste should be decontaminated before the disposal. The laboratory should include the cost of the decontamination in the analysis.

### Antimicrobial Resistance Context in the Decision Process

The decision process should also consider the antimicrobial resistance context. The World Health Organization [<a href="#ref-6">6</a>] defines antimicrobial resistance as the ability of a microorganism to resist the effects of an antimicrobial agent. The identification of the organism is the first step in the management of antimicrobial resistance.

The automated system can provide the identification of the organism in a shorter time. The shorter time can support the antimicrobial stewardship by providing the information for the selection of the appropriate antimicrobial therapy. The laboratory should consider the impact of the turnaround time on the antimicrobial stewardship program.

The automated system can also support the detection of the resistant strains. The identification of the organism can be used to detect the emergence of the resistant strains. The laboratory should consider the impact of the automated system on the detection of the resistant strains.

The laboratory should also consider the integration of the identification with the antimicrobial susceptibility testing. The Clinical and Laboratory Standards Institute provides standards-based guidance for antimicrobial susceptibility testing and related microbiology practices [<a href="#ref-1">1</a>]. The automated system should be compatible with the susceptibility testing method used by the laboratory.

## Frequently Asked Questions

### What is the main difference between conventional and automated identification systems?

Conventional methods rely on manual biochemical tests that require 24 to 72 hours for results. Automated systems use instrument-based detection or mass spectrometry to provide results in 4 to 24 hours with less hands-on labor.

### Which method is more accurate for microbial identification?

Both methods can be accurate when performed correctly. The accuracy of conventional methods depends on the skill of the technician and the number of tests performed. The accuracy of automated systems depends on the quality of the database and the coverage of the organism panel.

### How does the cost of automated systems compare to conventional methods?

Automated systems require a higher capital investment and higher consumable costs per test. The cost per test decreases as the volume of tests increases. Conventional methods have lower capital costs but higher labor costs per test.

### What is the turnaround time for conventional identification?

The turnaround time for conventional identification is typically 24 to 72 hours after the pure culture is obtained. The time depends on the number of tests performed and the incubation time of the tests.

### What is the turnaround time for automated identification?

The turnaround time for automated identification is typically 4 to 24 hours after the pure culture is obtained. MALDI-TOF MS can provide results in minutes after the pure culture is obtained.

### What is the role of the database in automated identification?

The database contains the reference profiles of the organisms that the system can identify. The laboratory must verify that the database includes the organisms relevant to its laboratory population. The database must be updated to include newly recognized species.

### How should the laboratory validate an automated identification system?

The laboratory should validate the system using a panel of organisms that are representative of the laboratory. The results of the validation should be compared to the results of the reference method. The validation should be documented and reviewed.

### What are the biosafety considerations for microbial identification?

The laboratory must assess the risk of the organisms being handled and use the appropriate containment and decontamination procedures. The laboratory should follow the biosafety principles described in the Biosafety in Microbiological and Biomedical Laboratories [<a href="#ref-5">5</a>].

## Using the Evidence

| Source | Best use in this topic | Important limitation |
|---|---|---|
| [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) | official guidance | Check the linked page for current local requirements |
| [Microbiology Resources](https://asm.org/) | official guidance | Check the linked page for current local requirements |
| [Antimicrobial Resistance](https://www.who.int/health-topics/antimicrobial-resistance) | official guidance | Check the linked page for current local requirements |

## Related Diagnostic Guides

- [MALDI-TOF Mass Spectrometry for Veterinary Microbial Identification](/knowledge/diagnostics/microbiology/maldi-tof-mass-spectrometry-for-veterinary-microbial-identification)
- [Antimicrobial Susceptibility Testing Methods: A Comparative Overview for Clinical Microbiology](/knowledge/diagnostics/microbiology/antimicrobial-susceptibility-testing-methods-a-comparative-overview-for-clinical-microbiology)
- [Microbial Identification Workflows: From Phenotypic to Molecular Methods](/knowledge/diagnostics/molecular/microbial-identification-workflows-from-phenotypic-to-molecular-methods)
- [Automated Nucleic Acid Extraction Systems: Selection Criteria and Workflow Integration](/knowledge/diagnostics/molecular/automated-nucleic-acid-extraction-systems-selection-criteria-and-workflow-integration)
- [Laboratory Animal Models in Veterinary Virology](/knowledge/diagnostics/microbiology/laboratory-animal-models-in-veterinary-virology)

## References and Further Reading

<a id="ref-1"></a>[<a href="#ref-1">1</a>] [Antimicrobial Susceptibility Testing](https://clsi.org/standards/products/microbiology). Clinical and Laboratory Standards Institute.

<a id="ref-2"></a>[<a href="#ref-2">2</a>] [Microbiology Resources](https://asm.org/). American Society for Microbiology.

<a id="ref-3"></a>[<a href="#ref-3">3</a>] [Culture Collections](https://www.atcc.org/). American Type Culture Collection.

<a id="ref-4"></a>[<a href="#ref-4">4</a>] [Bacteriological Analytical Manual](https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam). U.S. Food and Drug Administration.

<a id="ref-5"></a>[<a href="#ref-5">5</a>] [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html). CDC and NIH.

<a id="ref-6"></a>[<a href="#ref-6">6</a>] [Antimicrobial Resistance](https://www.who.int/health-topics/antimicrobial-resistance). World Health Organization.

> This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.